Global Diuretics Market Data 2024, Forecast To 2033
10 Jan, 2024
The diuretics market has experienced steady growth, increasing from $0.71 billion in 2023 to $0.75 billion in 2024, with a CAGR of 4.8%. Contributing factors include the prevalence of chronic diseases, an aging population, adherence to clinical guidelines, pharmaceutical innovation, and an increase in obesity. The market is expected to see continued steady growth, reaching $0.88 billion in 2028, with a CAGR of 4.2%. Key drivers include the rising incidence of hypertension and heart failure, growth in emerging markets, government initiatives, and a focus on preventive healthcare. Noteworthy trends include the adoption of personalized medicine, innovative drug development, telehealth and remote monitoring, and the integration of digital health solutions.
Global Diuretics Market Key Driver
Growing cases of renal and kidney disorders drive the diuretics market. Lifestyle changes contribute to the rise in kidney disorders, with over 37 million US adults suffering from chronic kidney diseases in 2021.
Get A Free Sample Of The Global Diuretics Market ReportGlobal Diuretics Market Segments
The diuretics market covered in this report is segmented –
1) By Type: Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides & Thiazide-Like Diuretics, Aldosterone Antagonists
2) By Distribution: Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
3) By Application: Hypertension, Glaucoma, Heart Failure, Kidney Stones
Sub-Segments
By Route of Administration: Intravenous, Oral
By Geography: The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the diuretics market in 2023. The Middle East is expected to be the fastest-growing region in the diuretics market during the forecast period. The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Diuretics Industry Players
Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, H. Lundbeck Inc., Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd, F Hoffmann-La Roche Ltd, Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.
Get The Full Global Diuretics Market Report
Diuretics Market Overview
Diuretic drugs refer to the drugs that help increase the flow of urine by reducing the concentration of sodium and chloride in the body. It helps the body eliminate salt (sodium) and water with these so-called ‘water tablets. Diuretic drugs include diuril, microzide, and indapamide.
Diuretics Global Market Report 2023 provides data on the global diuretics market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The diuretics market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.